Phase I Trial of Ex Vivo Expanded Donor Gamma Delta T Cell Immunotherapy to Prevent Acute Myeloid Leukemia Relapse after Allogeneic Transplantation

Nelli Bejanyan, Marco L. Davila, Jongphil Kim et al.|Transplantation and Cellular Therapy|2025

Cited by 1